These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8131569

  • 1. Pneumonitis associated with natural and recombinant interferon alfa therapy for chronic hepatitis C.
    Chin K, Tabata C, Sataka N, Nagai S, Moriyasu F, Kuno K.
    Chest; 1994 Mar; 105(3):939-41. PubMed ID: 8131569
    [Abstract] [Full Text] [Related]

  • 2. Hazards of interferon therapy for HBV-seronegative chronic hepatitis.
    Vento S, Di Perri G, Garofano T, Cosco L, Concia E, Ferraro T, Bassetti D.
    Lancet; 1989 Oct 14; 2(8668):926. PubMed ID: 2571851
    [No Abstract] [Full Text] [Related]

  • 3. Pneumonitis during interferon and/or herbal drug therapy in patients with chronic active hepatitis.
    Ishizaki T, Sasaki F, Ameshima S, Shiozaki K, Takahashi H, Abe Y, Ito S, Kuriyama M, Nakai T, Kitagawa M.
    Eur Respir J; 1996 Dec 14; 9(12):2691-6. PubMed ID: 8980988
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cardiogenic shock following recombinant alpha-2b interferon therapy for chronic hepatitis C. A case report.
    Teragawa H, Hondo T, Amano H, Watanabe H, Ohe H, Hattori N, Watanabe Y, Hino F, Ohbayashi M.
    Jpn Heart J; 1996 Jan 14; 37(1):137-42. PubMed ID: 8632622
    [Abstract] [Full Text] [Related]

  • 7. [An autopsied case of interstitial and infectious pneumonia appeared during interferon treatment for C-type chronic active hepatitis].
    Motegi K, Yamada S, Saruya S, Hayashi T, Otani N.
    Nihon Shokakibyo Gakkai Zasshi; 1994 Mar 14; 91(3):350-4. PubMed ID: 8145375
    [No Abstract] [Full Text] [Related]

  • 8. [A comparative randomized controlled study of the efficacy of interferon alfa-2b and interferon alfa-2a in the treatment of chronic hepatitis C].
    Fernández I, Castellano G, Canga F, Colina F, García H, Fuertes A, Casis B, Martín A, Solís JA.
    Gastroenterol Hepatol; 1995 Feb 14; 18(2):66-72. PubMed ID: 7621277
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Appearance of oral erosive lichen planus during interferon alfa-2a therapy for chronic active hepatitis C.
    Núñez M, Miralles ES, de las Heras ME, Ledo A.
    J Dermatol; 1995 Jun 14; 22(6):461-2. PubMed ID: 7650248
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Abducent nerve paralysis during interferon alpha-2a therapy in a case of chronic active hepatitis C.
    Fukumoto Y, Shigemitsu T, Kajii N, Omura R, Harada T, Okita K.
    Intern Med; 1994 Oct 14; 33(10):637-40. PubMed ID: 7827383
    [Abstract] [Full Text] [Related]

  • 15. Exacerbation of lichen planus during interferon alfa-2a therapy for chronic active hepatitis C.
    Protzer U, Ochsendorf FR, Leopolder-Ochsendorf A, Holtermüller KH.
    Gastroenterology; 1993 Mar 14; 104(3):903-5. PubMed ID: 8440441
    [Abstract] [Full Text] [Related]

  • 16. Randomized trial comparing three different regimens of interferon alfa 2a in chronic hepatitis C.
    Angelico M.
    Hepatology; 1996 Jun 14; 23(6):1709-10. PubMed ID: 8675201
    [No Abstract] [Full Text] [Related]

  • 17. [Esophageal candidiasis during interferon therapy for chronic viral hepatitis C].
    Prignet JM, Galzin M, Demarquay JF, Raynard B, Louvety S, Künkel D.
    Gastroenterol Clin Biol; 1994 Jun 14; 18(8-9):796-7. PubMed ID: 7875459
    [No Abstract] [Full Text] [Related]

  • 18. Interferon therapy for chronic hepatitis C.
    Davis GL.
    Baillieres Clin Gastroenterol; 1996 Jul 14; 10(2):289-98. PubMed ID: 8864035
    [Abstract] [Full Text] [Related]

  • 19. [Autoimmune thrombocytopenic purpura after treatment of chronic viral hepatitis C with interferon].
    Maïga MY, Oberti F, Foussard C, Calès P.
    Gastroenterol Clin Biol; 1995 Jul 14; 19(8-9):739-40. PubMed ID: 8522132
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.